OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Saad on Unique Characteristics of Apalutamide in M0CRPC

June 26th 2020

Fred Saad, MD, FRCS, discusses unique characteristics of apalutamide compared with other antiandrogen agents in nonmetastatic castration-resistant prostate cancer.

Dr. Sharman on ​the Challenges of Adjust​ing Treatment Based on MRD Status in CLL

June 26th 2020

Jeff P. Sharman, MD, discusses the challenges of adjusting treatments based on minimal residual disease status in high-risk chronic lymphocytic leukemia.

Dr. Kuruvilla on the Safety of Pembrolizumab in Classical Hodgkin Lymphoma

June 25th 2020

John Kuruvilla, MD, FRCPC, discusses the safety of pembrolizumab (Keytruda) versus brentuximab vedotin in classical Hodgkin lymphoma.

Dr. Berdeja on Next Steps With JNJ-4528 in Relapsed/Refractory Myeloma

June 25th 2020

Jesus G. Berdeja, MD, discusses next steps for the phase 2 CARTITUDE-1 study with JNJ-4528 in relapsed/refractory myeloma.

Dr. McKay on the Design of the PDIGREE Trial in Advanced RCC

June 25th 2020

Rana R. McKay, MD, discusses the design of the phase 3 PDIGREE study in advanced renal cell carcinoma.

Dr. Ramos on the Role of BCG In Non-Muscle Invasive Bladder Cancer

June 25th 2020

Félix Guerrero-Ramos, MD, PhD, FEBU, discusses the role of Bacillus Calmette-Guerin in the treatment of patients with non-muscle invasive bladder cancer.

Dr. Tykodi on the Efficacy of Dual Checkpoint Blockade in RCC

June 25th 2020

Scott S. Tykodi, MD, PhD, discusses the efficacy of dual checkpoint blockade in renal cell carcinoma.

Dr. Karmali on Optimizing Maintenance Therapy in Older Patients With MCL

June 24th 2020

Reem Karmali, MD, MS, discusses next steps for optimizing maintenance therapy in older patients with mantle cell lymphoma.

Dr. Jain on Future Research Efforts Examining Venetoclax Resistance Patterns in MCL

June 24th 2020

Preetesh Jain, MD, PhD, discusses research efforts examining resistance patterns with venetoclax in mantle cell lymphoma.

Dr. Moyers on Real-World Data With Adjuvant Immunotherapy in Melanoma

June 24th 2020

Justin Moyers, MD, discusses real-world data and sociodemographic factors from an early analysis of the National Cancer Database associated with the treatment of adjuvant immunotherapy in stage III melanoma.

Dr. Saba on the Future of Treatment in Head and Neck Cancer

June 24th 2020

Nabil F. Saba, MD, FACP, discusses the future of treatment in head and neck cancer.

Dr. Kuruvilla on the Broad Utility of Pembrolizumab in Hodgkin Lymphoma

June 24th 2020

John Kuruvilla, MD, FRCPC, discusses the broad utility of pembrolizumab in Hodgkin lymphoma.

Dr. Hill on the Safety Profile of Selinexor in Relapsed/Refractory DLBCL

June 24th 2020

Brian T. Hill, MD, PhD, discusses the safety profile of selinexor in relapsed/refractory diffuse large B-cell lymphoma.

Dr. Sokolova on Challenges of Germline Testing in Metastatic Prostate Cancer

June 24th 2020

Alexandra Sokolova, MD, discusses the challenges of germline testing in patients with metastatic prostate cancer. 

Dr. O’Malley on the Utility of Mirvetuximab in Ovarian Cancer

June 24th 2020

David O'Malley, MD, discusses the utility of mirvetuximab soravtansine in ovarian cancer.

Dr. Tseng on Role of Neoadjuvant Systemic Therapy in High-Risk Retroperitoneal Sarcoma

June 23rd 2020

William W. Tseng, MD, discusses the potential role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma.

Dr. Saad on the Safety Profile of Apalutamide in M0CRPC

June 23rd 2020

Fred Saad, MD, FRCS, discusses the safety profile of apalutamide in nonmetastatic castration-resistant prostate cancer.

Dr. Lee on B-Cell Receptor Targeting in Relapsed/Refractory MCL

June 23rd 2020

Hun Ju Lee, MD, discusses B-cell receptor targeting in relapsed/refractory mantle cell lymphoma.

Dr. Galsky on Sequencing Questions in Urothelial Cancer

June 23rd 2020

Matthew Galsky, MD, discusses sequencing questions in urothelial carcinoma.

Dr. Weber on Research Efforts Examining Neoadjuvant Approaches in Melanoma

June 23rd 2020

Jeffrey S. Weber, MD, PhD, discusses research efforts examining neoadjuvant approaches in melanoma.

NEXT PAGE
PREVIOUS PAGE